Skip to main content

Year: 2022

Correction: Horizon Therapeutics plc

                        FORM 8.3   IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE   1. KEY INFORMATION  Name of person dealing (Note 1) State Street Global Advisors & AffiliatesCompany dealt in Horizon Therapeutics plcClass of relevant security to which the dealings being disclosed relate (Note 2) $0.0001 ordinary sharesDate of dealing 13TH Dec 2022       2. INTERESTS AND SHORT POSITIONS   (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)    Long Short  Number (%) Number (%)(1) Relevant securities 5,823,747 2.56912%    (2) Derivatives (other than options) 508 0.000224%    (3) Options and agreements to...

Continue reading

At CAGR of 20.1%: Wi-Fi as a Service Market Size Projected to Reach worth $10.1 billion by 2026 – Report by MarketsandMarkets™

Chicago, Dec. 16, 2022 (GLOBE NEWSWIRE) — The global Wi-Fi as a Service Market is expected to reach USD 10.1 billion by 2026 from USD 4.0 billion in 2021, at a CAGR of 20.1 % during the forecast period, according to report by MarketsandMarkets. The increasing adoption of BYOD and CYOD trend among organizations is expected to drive the worldwide Wi-Fi as a Service market. Browse in-depth TOC on “Wi-Fi as a Service Market” 255 – Tables 40 – Figures 273 – Pages Download Report Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143023614 Scope of the ReportReport Attributes DetailsMarket size available for years 2017-2026Base year considered 2020Forecast period 2021-2026Market Size Value in 2021 USD 4.0 billionRevenue Forecast in 2026 USD 10.1 billion...

Continue reading

Rocky Mountain High Brands Reports Record Revenue of $2,185,450 Through September 30, 2022

PLANO, Texas, Dec. 16, 2022 (GLOBE NEWSWIRE) — Rocky Mountain High Brands, Inc. (OTC: RMHB) today reported financial results for the first three quarters of 2022. The Company reported record revenue of $2,185,450 representing the best third quarter year-to-date revenue in Company history and 642% year-over-year growth. The third quarter 2022 revenue was $1,376,141 which was a 664% increase over revenue for the third quarter of 2021. Revenue for the first quarter of 2022 was $121,352 representing a 101% increase over revenue for the first quarter of 2021. Revenue for the second quarter of 2022 was $687,978 representing an 828% increase over revenue for the second quarter of 2021. The Company made significant investments in additional production equipment, substantial leasehold improvements, and product development during 2021 and...

Continue reading

Verde Bio Holdings Provides Second Quarter Corporate Update

FRISCO, TX, Dec. 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Verde Bio Holdings, Inc. (OTCQB: VBHI), a growing oil and gas company, today issued its second quarter shareholder update, along with its 10-Q filing with the highlights of the Quarter and what is in store for the future. The Company remains very bullish on oil and gas and the growth and acquisition opportunities ahead. Verde has built an excellent portfolio and as commodity prices continue to rise, so does its revenue on a relative basis with no increased cost to Verde. Commenting on the results, CEO Scott Cox said: “I’m pleased to report another quarter of consistent execution towards our growth initiatives driven by the strategic expansion of our low-risk, long-life, low-decline asset acquisition model into complementary acquisitions. Looking forward,...

Continue reading

EnWave Reports Fourth Quarter and Annual 2022 Consolidated Financial Results

VANCOUVER, British Columbia, Dec. 16, 2022 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reported the Company’s consolidated financial results for the fourth quarter and fiscal year-ended September 30, 2022.Reported record annual royalty revenue of $1.35 million representing an increase of 47% over the prior year. Completed the facility construction and SQF certification at REVworx and developed a robust pipeline of commercial tolling opportunities with global food companies. Maintained a consolidated gross margin of 27% in an inflationary economic backdrop. Reported an Adjusted EBITDA(1) loss of $3.4 million, largely due to input price increases and low economies of scale in NutraDried’s segment. EnWave’s pipeline of prospective new royalty-bearing license and machine...

Continue reading

Digerati Technologies Reports 115% Revenue Growth to $8.1 Million for First Quarter FY2023

– Non-GAAP Adjusted Operating EBITDA of $1.3 Million –– Merger with MEOA SPAC Targeted to Close in First Quarter Calendar 2023 – SAN ANTONIO, Dec. 16, 2022 (GLOBE NEWSWIRE) — Digerati Technologies, Inc. (OTCQB: DTGI) (“Digerati” or the “Company”), a provider of cloud services specializing in UCaaS (Unified Communications as a Service) solutions for the small to medium-sized business (“SMB”) market, announced today financial results for the three months ended October 31, 2022, the Company’s first quarter for its Fiscal Year 2023. Key Financial Highlights for the First Quarter Fiscal Year 2023 (Ended October 31, 2022)Revenue increased by 115% to $8.1 million compared to $3.8 million for Q1 FY2022. Gross profit increased 131% to $5.3 million compared to $2.3 million for Q1 FY2022. Gross...

Continue reading

Hospital Capacity Management Solutions Market worth $7.0 billion by 2026 – Exclusive Report by MarketsandMarkets™

Chicago, Dec. 16, 2022 (GLOBE NEWSWIRE) — According to the new market research report “Hospital Capacity Management Solutions Market by Product (Asset, Bed Management, Nurse Scheduling, Patient Flow Management), Component (Software, Integrated, Services), Delivery Mode (On-premises, Cloud), End User (Hospitals, ASC) – Global Forecast to 2026″, The global hospital capacity management solutions market is projected to reach USD 7.0 billion by 2026 from USD 3.2 billion in 2021, at a CAGR of 17.1% during the forecast period. Browse in-depth TOC on “Hospital Capacity Management Solutions Market“213 – Tables40 – Figures228 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=25396768 Scope of the Report:Report Coverage DetailsMarket Size USD...

Continue reading

Lelantos Holdings, Inc. Announces an Update on Its Merger Process and Acquisition of Lelantos Energy

LAS VEGAS, Dec. 16, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Lelantos Holdings, Inc. (OTC PINK: LNTO) (“Lelantos” or the “Company”), formerly ProConcept Marketing Group, Inc., is pleased to announce an update in regard to finalizing its merger which is intended to fully complete the process of establishing Lelantos Holdings as a public entity on the OTC Market. The company was already approved by FINRA for its name change, symbol change, and reverse split and currently trades under the symbol LNTO. To finalize this process, on Nov. 14, 2022, Lelantos Holdings Inc., a Florida entity, filed the required Articles of Merger merging Lelantos Holdings Incorporated, a Nevada corporation, into the Company with a requested effective date of Nov. 22, 2022. Due to the current document processing delays of over three months in the...

Continue reading

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2023 Financial Results

Patient Enrollment Close to Completion and Continue to Target FDA De Novo Resubmission Around Current Fiscal Year End Southlake, Texas, Dec. 16, 2022 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more valuable screening tool through the use of Artificial Intelligence (AI), today provided a business update and reported financial results for the fiscal 2023 second quarter ended October 31, 2022. Andrew Simpson, Chief Executive Officer of HeartSciences, stated, “Since our initial public offering in June 2022, we have achieved a number of important milestones which add to HeartSciences’ strategic value as we progress towards commercialization of the MyoVista®. ...

Continue reading

The First of Long Island Corporation Announces Fourth Quarter Cash Dividend of $.21 Per Share

MELVILLE, N.Y., Dec. 16, 2022 (GLOBE NEWSWIRE) — The First of Long Island Corporation (Nasdaq: FLIC) announced today the declaration of a fourth quarter cash dividend in the amount of $.21 per share. This represents a 5.0% increase over the dividend of $.20 per share declared in the same quarter last year. The dividend will be paid on January 12, 2023 to shareholders of record on January 3, 2023. The First of Long Island Corporation is the parent company of The First National Bank of Long Island. Through its branch network branded as First National Bank LI, the Bank focuses on business and consumer needs on Long Island and in New York City. We offer a broad set of lending, deposit, investment, and digital products. First National Bank LI is known for its culture of delivering extraordinary service and a “Customer First” banking...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.